Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium

Journal of Molecular Neuroscience

Volumn 33, Issue 3, 2007, Pages 262-267

  Arakawa, Tsutomu ^a   Niikura, Takako ^b,d   Tajima, Hirohisa ^c,d   Arisaka, Fumio ^e   Kita, Yoshiko ^d  

^a ALLIANCE PROTEIN LABORATORIES   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

ADNF; Circular dichroism; Disordered secondary structure; Molecular weight; Sedimentation equilibrium

Indexed keywords

NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; BRAIN CELL; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; SEDIMENTATION; STRUCTURE ANALYSIS;

ANIMALS; CELLS, CULTURED; CIRCULAR DICHROISM; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; PROTEIN STRUCTURE, SECONDARY; ULTRACENTRIFUGATION;

EID: 36949008553     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-007-0032-5     Document Type: Article

References (18)

1. Arakawa, T., Niikura, T., Tajima, H., & Kita, Y. (2006). The secondary structure analysis of a potent Ser14Gly analog of anti-Alzheimer peptide, Humanin, by circular dichroism. Journal of Peptide Science, 12, 639-642.
2. Bohm, G., Muhr, G., & Jaenicke, R. (1992). Quantitative analysis of protein far UV circular dichroism spectra by neural net works. Protein Engineering, 5, 191-195.
3. Brenneman, D. E., & Gozes, I. (1996). A femtomolar-acting neuroprotective peptide. Journal of Clinical Investigation, 97, 2299-2307.
4. Brenneman, D. E., Hauser, J., Neale, E., Rubinraut, S., Fridkin, M., Davidson, A., et al. (1998). Activity-dependent neurotrophic factor: Structure-activity relationships of femtomolar-acting peptides. Journal of Pharmacology and Experimental Therapeutics, 285, 619-627.
5. Chiba, T., Hashimoto, Y., Tajima, H., Yamada, M., Koto, R., Niikura, T., et al. (2004). Neuroprotective effect of activity-dependent neurotrophic factor, ADNF, against toxicity by familial amyotrophic lateral sclerosis-linked mutant SOD1 in vitro and in vivo. Journal of Neuroscience Research, 78, 542-552.
6. Chiba, T., Yamada, M., Hashimoto, Y., Sato, M., Sasabe, J., Kita, Y., et al. (2005). Development of a femtomolar-acting humanin derivative named Colivelin by attaching activity-dependent neurotrophic factor to its N terminus: Characterization of Colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo. Journal of Neuroscience, 25, 10252-10261.
7. Fox, G. M., Schiffer, S. G., Rohde, M. F., Tsai, L. B., Banks, A. R., & Arakawa, T. (1988). Production, biological activity, and structure of recombinant basic fibroblast growth factor and in analog with cysteine replaced by serine. Journal of Biological Chemistry, 263, 18452-18458.
8. Hashimoto, Y., Ito, Y., Niikura, T., Shao, Z., Hata, M., Oyama, F., et al. (2001a). Mechanisms of neuroprotection by a novel rescue factor Humanin from Swedish mutant amyloid precursor protein. Biochemical and Biophysical Research Communications, 283, 460-468.
9. Hashimoto, Y., Niikura, T., Ito, Y., Sudo, H., Hata, M., Arakawa, E., et al. (2001b). Detailed characterization of neuroprotection by a rescue factor Humanin against various Alzheimer's disease-relevant insults. Journal of Neuroscience, 21, 9235-9245.
10. Hashimoto, Y., Niikura, T., Tajima, H., Yasukawa, T., Sudo, H., Ito, Y., et al. (2001c). A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proceedings of the National Academy of Sciences of the United States of America, 98, 6336-6341.
11. Jung, S. S., & van Nostrand, W. E. (2003). Humanin rescues human cerebrovascular smooth muscle cells from Aβ-induced toxicity. Journal of Neurochemistry, 84, 266-272.
12. Laue, T. M., Shah, B. D., Ridgeway, T. M., & Pelletier, S. L. (1992). Computer-aided interpretation of analytical sedimentation data for proteins. In S. E. Harding, A. J. Rowe, & J. C. Horton (Eds.), Analytical centrifugation in biochemistry and polymer science (pp. 90-125). Cambridge, United Kingdom: Royal Society of Chemistry.
13. Misono, K. (2000). Atriuretic natriuretic factor binding to its receptor is dependent on chloride concentration. A possible feedback-control mechanism in renal salt regulation. Circulation Research, 86, 1135-1139.
14. Niikura, T., Tajima, H., & Kita, Y. (2006). Neuronal cell death in Alzheimer's disease and a neuroprotective factor, Humanin. Current Neuropharmacology, 4, 139-147.
15. Niikura, T., Yamada, M., Chiba, T., Aiso, S., Matsuoka, M., & Nishimoto, I. (2004). Characterization of V642I-APP-induced cytotoxicity in primary neurons. Journal of Neuroscience Research, 77, 54-62.
16. Philo, J. S., Aoki, K. H., Arakawa, T., Narhi, L. O., & Wen, J. (1996). Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: One high-affinity and one low-affinity interaction. Biochemistry, 35, 1681-1691.
17. Terashita, K., Hashimoto, Y., Niikura, T., Tajima, H., Yamagishi, Y., Ishizaka, M., et al. (2003). Two serine residues distinctly regulate the rescue function of Humanin, an inhibiting factor of Alzheimer's disease-related neurotoxicity: Functional potentiation by isomerization and dimerization. Journal of Neurochemistry, 85, 1521-1538.
18. Yamagishi, Y., Hashimoto, Y., Niikura, T., & Nishimoto, I. (2003). Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer's disease-relevant insults. Peptides, 24, 585-595.